OrganoClick AB (FRA:0CF) 5-Year EBITDA Growth Rate: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:0CF OrganoClick AB FRA:0CF
25 GF Score
Price €0.03
GF Value €0.13
! 4 Warning Signs
View Full Analysis

What is OrganoClick AB 5-Year EBITDA Growth Rate?

OrganoClick AB FRA:0CF -18.07% 25 5-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus rates FRA:0CF with a GF Score™ of 25/100 and a GF Value™ of €0.13. The stock has 4 warning signs investors should review.

OrganoClick AB's EBITDA per Share for the three months ended in Mar. 2026 was €0.00.

During the past 12 months, OrganoClick AB's average EBITDA Per Share Growth Rate was -388.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 16.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of OrganoClick AB was 53.00% per year. The lowest was -78.20% per year. And the median was 3.50% per year.

OrganoClick AB  (FRA:0CF) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

OrganoClick AB 5-Year EBITDA Growth Rate Related Terms

FRA:0CF vs LIN, SHW, ECL: 5-Year EBITDA Growth Rate Comparison

For the Specialty Chemicals subindustry, OrganoClick AB's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OrganoClick AB 5-Year EBITDA Growth Rate vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, OrganoClick AB's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where OrganoClick AB's 5-Year EBITDA Growth Rate falls into.


FRA:0CF
25GF Score
OrganoClick AB FRA:0CF
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OrganoClick AB 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
OrganoClick AB (FRA:0CF) has a 5-Year EBITDA Growth Rate of 0.00% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for OrganoClick AB and its competitors.
Is OrganoClick AB's 5-Year EBITDA Growth Rate too high?
OrganoClick AB's current 5-Year EBITDA Growth Rate is 0.00%. Overall, OrganoClick AB has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does OrganoClick AB's 5-Year EBITDA Growth Rate compare to LIN and SHW?
OrganoClick AB's 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Chemicals company?
A good 5-Year EBITDA Growth Rate depends on the Chemicals industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for OrganoClick AB and its competitors. OrganoClick AB's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrganoClick AB stock overvalued right now?
OrganoClick AB (FRA:0CF) has a current 5-Year EBITDA Growth Rate of 0.00%. The stock's GF Value™ is €0.13, compared to a current price of €0.03 — trading 79.1% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 0.00%. OrganoClick AB's overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For OrganoClick AB (FRA:0CF), the current 5-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OrganoClick AB (FRA:0CF) Overvalued in 2026?

Based on GuruFocus' analysis, OrganoClick AB stock appears to be undervalued. The current stock price of €0.03 is trading 79.1% below its estimated GF Value™ of €0.13.

Key valuation signals for FRA:0CF:

  • 5-Year EBITDA Growth Rate: 0.00%
  • GF Value™: €0.13 vs. price of €0.03 (79.1% below fair value)
  • GF Score™: 25/100 with 4 warning signs

No single metric tells the full story. See the FRA:0CF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OrganoClick AB Business Description

Other Exchanges ORGC:Sweden
Address Linjalvagen 9, Taby, SWE, SE-187 66
OrganoClick AB is involved in the chemicals industry. Its product portfolio includes green chemical technologies for creating water repellency, biobased binders for increasing the mechanical strength, and wood treatment products for resistance to fungal degradation and resistance to fire. It operates in four business areas Functional Wood, Green coatings & maintenance products, Nonwoven & technical textile, and Other. The group has a single operating segment.
25GF Score

Get the complete analysis for FRA:0CF

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price
€0.13
GF Value